Literature DB >> 16621793

Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.

Elisabeth M Chalovich1, Jian-hui Zhu, John Caltagarone, Robert Bowser, Charleen T Chu.   

Abstract

Impaired survival signaling may represent a central mechanism in neurodegeneration. 6-Hydroxydopamine (6-OHDA) is an oxidative neurotoxin used to injure catecholaminergic cells of the central and peripheral nervous systems. Although 6-OHDA elicits phosphorylation of several kinases, downstream transcriptional effects that influence neuronal cell death are less defined. The cAMP response element (CRE) is present in the promoter sequences of several important neuronal survival factors. Treatment of catecholaminergic neuronal cell lines (B65 and SH-SY5Y) with 6-OHDA resulted in repression of basal CRE transactivation. Message levels of CRE-driven genes such as brain-derived neurotrophic factor and the survival factor Bcl-2 were decreased in 6-OHDA-treated cells, but message levels of genes lacking CRE sequences were not affected. Repression of CRE could be reversed by delayed treatment with cAMP several hours after initiation of 6-OHDA injury. Furthermore, restoration of CRE-driven transcription was associated with significant neuroprotection. In contrast to observations in other model systems, the mechanism of CRE repression did not involve decreased phosphorylation of its binding protein CREB. Instead, total CREB and phospho-CREB (pCREB) were increased in the cytoplasm and decreased in the nucleus of 6-OHDA-treated cells. 6-OHDA also decreased nuclear pCREB in dopaminergic neurons of primary mouse midbrain cultures. Co-treatment with cAMP promoted/restored nuclear localization of pCREB in both immortalized and primary culture systems. Increased cytoplasmic pCREB was observed in degenerating human Parkinson/Lewy body disease substantia nigra neurons but not in age-matched controls. Notably, cytoplasmic accumulation of activated upstream CREB kinases has been observed previously in both 6-OHDA-treated cells and degenerating human neurons, supporting a potential role for impaired nuclear import of phosphorylated signaling proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621793      PMCID: PMC1876691          DOI: 10.1074/jbc.M602632200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Fetal Alz-50 clone 1, a novel zinc finger protein, binds a specific DNA sequence and acts as a transcriptional regulator.

Authors:  K L Jordan-Sciutto; J M Dragich; J L Rhodes; R Bowser
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.

Authors:  X Guo; V L Dawson; T M Dawson
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

3.  Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.

Authors:  Charleen T Chu; Jian-hui Zhu; Guodong Cao; Armando Signore; Suping Wang; Jun Chen
Journal:  J Neurochem       Date:  2005-09       Impact factor: 5.372

4.  Oxidant-mediated cAMP response element binding protein activation: calcium regulation and role in apoptosis of lung epithelial cells.

Authors:  Christy A Barlow; Arti Shukla; Brooke T Mossman; Karen M Lounsbury
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-08       Impact factor: 6.914

5.  Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival.

Authors:  Junghee Lee; Chun-Hyung Kim; David K Simon; Lyaylya R Aminova; Alexander Y Andreyev; Yulia E Kushnareva; Anne N Murphy; Bonnie E Lonze; Kwang-Soo Kim; David D Ginty; Robert J Ferrante; Hoon Ryu; Rajiv R Ratan
Journal:  J Biol Chem       Date:  2005-10-05       Impact factor: 5.157

6.  Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer.

Authors:  R L Klein; M H Lewis; N Muzyczka; E M Meyer
Journal:  Brain Res       Date:  1999-11-20       Impact factor: 3.252

Review 7.  Autophagic stress in neuronal injury and disease.

Authors:  Charleen T Chu
Journal:  J Neuropathol Exp Neurol       Date:  2006-05       Impact factor: 3.685

Review 8.  Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease.

Authors:  Serge Przedborski; Harry Ischiropoulos
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

9.  Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.

Authors:  Jason Callio; Tim D Oury; Charleen T Chu
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

10.  Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.

Authors:  Agnes Petit; Toshitaka Kawarai; Erwan Paitel; Nobuo Sanjo; Mary Maj; Michael Scheid; Fusheng Chen; Yongjun Gu; Hiroshi Hasegawa; Shabnam Salehi-Rad; Linda Wang; Ekaterina Rogaeva; Paul Fraser; Brian Robinson; Peter St George-Hyslop; Anurag Tandon
Journal:  J Biol Chem       Date:  2005-08-02       Impact factor: 5.157

View more
  45 in total

1.  Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.

Authors:  R K Dagda; A M Gusdon; I Pien; S Strack; S Green; C Li; B Van Houten; S J Cherra; C T Chu
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Expression of Nrf2 in neurodegenerative diseases.

Authors:  Chenere P Ramsey; Charles A Glass; Marshall B Montgomery; Kathryn A Lindl; Gillian P Ritson; Luis A Chia; Ronald L Hamilton; Charleen T Chu; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

Review 3.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

Review 4.  CREB: a multifaceted regulator of neuronal plasticity and protection.

Authors:  Kensuke Sakamoto; Kate Karelina; Karl Obrietan
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

Review 5.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

6.  Autophagy in neuroprotection and neurodegeneration: A question of balance.

Authors:  Salvatore J Cherra; Charleen T Chu
Journal:  Future Neurol       Date:  2008-05

7.  Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease.

Authors:  Ruben K Dagda; Jianhui Zhu; Scott M Kulich; Charleen T Chu
Journal:  Autophagy       Date:  2008-06-16       Impact factor: 16.016

Review 8.  Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis.

Authors:  Ruben K Dagda; Charleen T Chu
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

9.  Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

Authors:  Vivek P Patel; Donald B Defranco; Charleen T Chu
Journal:  Biochim Biophys Acta       Date:  2012-08-08

10.  Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death.

Authors:  Hyung-Wook Kim; Yunyoung C Chang; Mei Chen; Stanley I Rapoport; Jagadeesh S Rao
Journal:  BMC Neurosci       Date:  2009-09-28       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.